1. Home
  2. DRS
  3. Earnings

AI Earnings Predictions for Leonardo DRS Inc. (DRS)

Machine learning predictions based on historical earnings data and price patterns

Latest Prediction

BUY

1-Day Prediction

+0.43%

$44.01

100% positive prob.

5-Day Prediction

+5.86%

$46.39

100% positive prob.

20-Day Prediction

+5.74%

$46.33

95% positive prob.

Price at prediction: $43.82 Confidence: 100.0% Model AUC: 1.0000 Quarter: Q4 2025

Earnings Transcripts

SEC 8-K filings with transcript text

View All
2025
Q4

Q4 2025 Earnings

8-K BUY

Feb 24, 2026 · 100% conf.

AI Prediction BUY

1D

+0.43%

$44.01

Act: -3.33%

5D

+5.86%

$46.39

Act: +3.01%

20D

+5.74%

$46.33

Price: $43.82 Prob +5D: 100% AUC: 1.000
0001833756-26-000009

drs-20260224FALSE000183375600018337562026-02-242026-02-24

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2026


LEONARDO DRS, INC.

(Exact name of registrant as specified in its charter)


Delaware 001-41565 13-2632319

(State of Incorporation) (Commission File Number) (IRS Employer Identification Number)

2345 Crystal Drive Suite 1000 Arlington, Virginia 22202 (Address of principal executive offices) (703) 416-8000 (Registrant's telephone number, including area code)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of class Trading Symbol Name of each exchange on which registered

Common Stock, $0.01 par value DRS The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

Item 2.02. Results of Operation and Financial Condition. On February 24, 2026, Leonardo DRS, Inc. (the “Company”) issued a news release reporting, among other things, its financial results for the fourth quarter and full year ended December 31, 2025 and providing its financial outlook for full year 2026. A copy of the news release is furnished as Exhibit 99.1 to this report. The Company’s management will discuss operations and financial results in a previously announced earnings conference call beginning at 10:00 a.m. Eastern Time on February 24, 2026. A live audio broadcast of the conference call along with a supplemental presentation will be available to the public through links on the Investor Relations section of the Company’s web site (https://investors.leonardodrs.com/). The information furnished pursuant to this Form 8-K (including the exhibits hereto) shall not be considered “filed” under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or under the Exchange Act, unless the Company expressly states in such filing that such information is to be considered “filed” or incorporated by reference therein. Item 7.01. Regulation FD Disclosure. The information in Item 2.02 of this Form 8-K is incorporated by reference into this Item 7.01. Item 9.01. Financial Statements and Exhibits. (d) Exhibits.

Exhibit NumberExhibit Description 99.1Leonardo DRS, Inc. News Release dated February 24, 2026 (earnings release reporting Leonardo DRS, Inc.'s financial results for the quarter and full year ended December 31, 2025).

104Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LEONARDO DRS, INC.

(Registrant)

Date: February 24, 2026 By: /s/ Mark A. Dorfman

Mark A. Dorfman

Executive Vice President, General Counsel and Secretary

2025
Q3

Q3 2025 Earnings

8-K

Oct 29, 2025

0001833756-25-000007

drs-20251029FALSE000183375600018337562025-10-292025-10-29

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2025


LEONARDO DRS, INC.

(Exact name of registrant as specified in its charter)


Delaware001-4156513-2632319 (State of Incorporation)(Commission File Number)(IRS Employer Identification Number)

2345 Crystal Drive Suite 1000 Arlington, Virginia 22202 (Address of principal executive offices) (703) 416-8000 (Registrant's telephone number, including area code)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of class Trading Symbol Name of each exchange on which registered

Common Stock, $0.01 par value DRS The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

Item 2.02. Results of Operation and Financial Condition. On October 29, 2025, Leonardo DRS, Inc. (the “Company”) issued a news release reporting, among other things, its financial results for the third quarter ended September 30, 2025. A copy of the news release is furnished as Exhibit 99.1 to this report. The Company’s management will discuss operations and financial results in an earnings conference call beginning at 9:30 a.m. Eastern Time on October 29, 2025. A live audio broadcast of the conference call along with a supplemental presentation will be available to the public through links on the Investor Relations section of the Company’s web site (https://investors.leonardodrs.com/). The information furnished pursuant to this Form 8-K (including the exhibits hereto) shall not be considered “filed” under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or under the Exchange Act, unless the Company expressly states in such filing that such information is to be considered “filed” or incorporated by reference therein. Item 7.01. Regulation FD Disclosure. The information in Item 2.02 of this report is incorporated by reference into this Item 7.01. Item 9.01. Financial Statements and Exhibits. (d) Exhibits.

Exhibit NumberExhibit Description 99.1Leonardo DRS, Inc. News Release dated October 29, 2025 (earnings release reporting Leonardo DRS, Inc.'s financial results for the quarter ended September 30, 2025).

104Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LEONARDO DRS, INC.

(Registrant)

Date: October 29, 2025 By: /s/ Mark A. Dorfman

Mark A. Dorfman

Executive Vice President, General Counsel and Secretary

2025
Q2

Q2 2025 Earnings

8-K

Jul 30, 2025

0001628280-25-036557

drs-20250730FALSE000183375600018337562025-07-302025-07-30

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2025


LEONARDO DRS, INC.

(Exact name of registrant as specified in its charter)


Delaware001-4156513-2632319 (State of Incorporation)(Commission File Number)(IRS Employer Identification Number)

2345 Crystal Drive Suite 1000 Arlington, Virginia 22202 (Address of principal executive offices) (703) 416-8000 (Registrant's telephone number, including area code)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of class Trading Symbol Name of each exchange on which registered

Common Stock, $0.01 par value DRS The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

Item 2.02. Results of Operation and Financial Condition. On July 30, 2025, Leonardo DRS, Inc. (the “Company”) issued a news release reporting, among other things, its financial results for the second quarter ended June 30, 2025. A copy of the news release is furnished as Exhibit 99.1 to this report. The Company’s management will discuss operations and financial results in an earnings conference call beginning at 10:00 a.m. Eastern Time on July 30, 2025. A live audio broadcast of the conference call along with a supplemental presentation will be available to the public through links on the Investor Relations section of the Company’s web site (https://investors.leonardodrs.com/). The information furnished pursuant to this Form 8-K (including the exhibits hereto) shall not be considered “filed” under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or under the Exchange Act, unless the Company expressly states in such filing that such information is to be considered “filed” or incorporated by reference therein. Item 7.01. Regulation FD Disclosure. The information in Item 2.02 of this report is incorporated by reference into this Item 7.01. Item 9.01. Financial Statements and Exhibits. (d) Exhibits.

Exhibit NumberExhibit Description 99.1Leonardo DRS, Inc. News Release dated July 30, 2025 (earnings release reporting Leonardo DRS, Inc.'s financial results for the quarter ended June 30, 2025).

104Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LEONARDO DRS, INC.

(Registrant)

Date: July 30, 2025 By: /s/ Mark A. Dorfman

Mark A. Dorfman

Executive Vice President, General Counsel and Secretary

2025
Q1

Q1 2025 Earnings

8-K

May 1, 2025

0001628280-25-021328

drs-20250501FALSE000183375600018337562025-05-012025-05-01

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2025


LEONARDO DRS, INC.

(Exact name of registrant as specified in its charter)


Delaware001-4156513-2632319 (State of Incorporation)(Commission File Number)(IRS Employer Identification Number)

2345 Crystal Drive Suite 1000 Arlington, Virginia 22202 (Address of principal executive offices) (703) 416-8000 (Registrant's telephone number, including area code)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of class Trading Symbol Name of each exchange on which registered

Common Stock, $0.01 par value DRS Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

Item 2.02. Results of Operation and Financial Condition. On May 1, 2025, Leonardo DRS, Inc. (the “Company”) issued a news release reporting, among other things, its financial results for the first quarter ended March 31, 2025. A copy of the news release is furnished as Exhibit 99.1 to this report. The Company’s management will discuss operations and financial results in an earnings conference call beginning at 10:00 a.m. Eastern Time on May 1, 2025. A live audio broadcast of the conference call along with a supplemental presentation will be available to the public through links on the Investor Relations section of the Company’s web site (https://investors.leonardodrs.com/). The information furnished pursuant to this Form 8-K (including the exhibits hereto) shall not be considered “filed” under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or under the Exchange Act, unless the Company expressly states in such filing that such information is to be considered “filed” or incorporated by reference therein. Item 7.01 Regulation FD Disclosure. The information in Item 2.02 of this report is incorporated by reference into this Item 7.01. Item 9.01. Financial Statements and Exhibits. (d) Exhibits.

Exhibit NumberExhibit Description 99.1Leonardo DRS, Inc. News Release dated May 1, 2025 (earnings release reporting Leonardo DRS, Inc.'s financial results for the quarter ended March 31, 2025).

104Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LEONARDO DRS, INC.

(Registrant)

Date: May 1, 2025 By: /s/ Mark A. Dorfman

Mark A. Dorfman

Executive Vice President, General Counsel and Secretary

2024
Q4

Q4 2024 Earnings

8-K

Feb 20, 2025

0001628280-25-006563

drs-20250220FALSE000183375600018337562025-02-202025-02-20

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 20, 2025


LEONARDO DRS, INC.

(Exact name of registrant as specified in its charter)


Delaware001-4156513-2632319 (State of Incorporation)(Commission File Number)(IRS Employer Identification Number)

2345 Crystal Drive Suite 1000 Arlington, Virginia 22202 (Address of principal executive offices) (703) 416-8000 (Registrant's telephone number, including area code)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of class Trading Symbol Name of each exchange on which registered

Common Stock, $0.01 par value DRS Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

Item 2.02. Results of Operation and Financial Condition. On February 20, 2025, Leonardo DRS, Inc. (the “Company”) issued a news release reporting, among other things, its financial results for the fourth quarter and full year ended December 31, 2024 and providing its financial outlook for full year 2025. A copy of the news release is furnished as Exhibit 99.1 to this report. The Company’s management will discuss operations and financial results in a previously announced earnings conference call beginning at 10:00 a.m. Eastern Time on February 20, 2025. A live audio broadcast of the conference call along with a supplemental presentation will be available to the public through links on the Investor Relations section of the Company’s web site (https://investors.leonardodrs.com/). The information furnished pursuant to this Form 8-K (including the exhibits hereto) shall not be considered “filed” under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or under the Exchange Act, unless the Company expressly states in such filing that such information is to be considered “filed” or incorporated by reference therein.

Item 7.01 Regulation FD Disclosure. The information in Item 2.02 of this Form 8-K is incorporated by reference into this Item 7.01.

Item 8.01 Other Events. On February 20, 2025, the Company announced that its Board of Directors approved the payment of a dividend. The Board declared a dividend in the amount of $0.09 per share, which will be paid on March 27, 2025 to stockholders of record as of the close of business on March 13, 2025. Future dividends will be subject to the approval of the Board of Directors. Additionally, the Company announced that its Board of Directors authorized a stock repurchase program for the Company to purchase up to $75 million of its outstanding common stock, at its discretion, commencing March 2025 and expiring March 2027. Under the stock repurchase program, the Company may purchase shares of its common stock through various means, including open market transactions, block purchases, privately negotiated transactions or otherwise in accordance with applicable federal securities laws, including Rule 10b-18 of the Securities Exchange Act of 1934, as amended. The timing and actual number of shares repurchased are subject to market conditions and legal requirements. The program may be modified, discontinued or suspended at any time without prior notice.

Item 9.01. Financial Statements and Exhibits. (d) Exhibits.

Exhibit NumberExhibit Description 99.1Leonardo DRS, Inc. News Release dated February 20, 2025 (earnings release reporting Leonardo DRS, Inc.'s financial results for the quarter and full year ended December 31, 2024).

104Cove

2024
Q3

Q3 2024 Earnings

8-K

Oct 30, 2024

0001628280-24-044191

drs-20241030FALSE000183375600018337562024-10-302024-10-30

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2024


LEONARDO DRS, INC.

(Exact name of registrant as specified in its charter)


Delaware001-4156513-2632319 (State of Incorporation)(Commission File Number)(IRS Employer Identification Number)

2345 Crystal Drive Suite 1000 Arlington, Virginia 22202 (Address of principal executive offices) (703) 416-8000 (Registrant's telephone number, including area code)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of class Trading Symbol Name of each exchange on which registered

Common Stock, $0.01 par value DRS Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

Item 2.02. Results of Operation and Financial Condition. On October 30, 2024, Leonardo DRS, Inc. (the “Company”) issued a news release reporting, among other things, its financial results for the third quarter ended September 30, 2024. A copy of the news release is furnished as Exhibit 99.1 to this report. The Company’s management will discuss operations and financial results in an earnings conference call beginning at 10:00 a.m. Eastern Time on October 30, 2024. A live audio broadcast of the conference call along with a supplemental presentation will be available to the public through links on the Investor Relations section of the Company’s web site (https://investors.leonardodrs.com/). The information furnished pursuant to this Form 8-K (including the exhibits hereto) shall not be considered “filed” under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or under the Exchange Act, unless the Company expressly states in such filing that such information is to be considered “filed” or incorporated by reference therein. Item 7.01 Regulation FD Disclosure. The information in Item 2.02 of this report is incorporated by reference into this Item 7.01. Item 9.01. Financial Statements and Exhibits. (d) Exhibits.

Exhibit NumberExhibit Description 99.1Leonardo DRS, Inc. News Release dated October 30, 2024 (earnings release reporting Leonardo DRS, Inc.'s financial results for the quarter ended September 30, 2024).

104Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LEONARDO DRS, INC.

(Registrant)

Date: October 30, 2024 By: /s/ Mark A. Dorfman

Mark A. Dorfman

Executive Vice President, General Counsel and Secretary

2024
Q2

Q2 2024 Earnings

8-K

Jul 30, 2024

0001628280-24-033350

drs-20240730FALSE000183375600018337562024-07-302024-07-30

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2024


LEONARDO DRS, INC.

(Exact name of registrant as specified in its charter)


Delaware001-4156513-2632319 (State of Incorporation)(Commission File Number)(IRS Employer Identification Number)

2345 Crystal Drive Suite 1000 Arlington, Virginia 22202 (Address of principal executive offices) (703) 416-8000 (Registrant's telephone number, including area code)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of class Trading Symbol Name of each exchange on which registered

Common Stock, $0.01 par value DRS Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

Item 2.02. Results of Operation and Financial Condition. On July 30, 2024, Leonardo DRS, Inc. (the “Company”) issued a news release reporting, among other things, its financial results for the second quarter ended June 30, 2024. A copy of the news release is furnished as Exhibit 99.1 to this report. The Company’s management will discuss operations and financial results in an earnings conference call beginning at 10:00 a.m. Eastern Time on July 30, 2024. A live audio broadcast of the conference call along with a supplemental presentation will be available to the public through links on the Investor Relations section of the Company’s web site (https://investors.leonardodrs.com/). The information furnished pursuant to this Form 8-K (including the exhibits hereto) shall not be considered “filed” under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or under the Exchange Act, unless the Company expressly states in such filing that such information is to be considered “filed” or incorporated by reference therein. Item 7.01 Regulation FD Disclosure. The information in Item 2.02 of this report is incorporated by reference into this Item 7.01. Item 9.01. Financial Statements and Exhibits. (d) Exhibits.

Exhibit NumberExhibit Description 99.1Leonardo DRS, Inc. News Release dated July 30, 2024 (earnings release reporting Leonardo DRS, Inc.'s financial results for the quarter ended June 30, 2024).

104Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LEONARDO DRS, INC.

(Registrant)

Date: July 30, 2024 By: /s/ Mark A. Dorfman

Mark A. Dorfman

Executive Vice President, General Counsel and Secretary

2024
Q1

Q1 2024 Earnings

8-K

May 1, 2024

0001628280-24-019471

drs-20240501FALSE000183375600018337562024-05-012024-05-01

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2024


LEONARDO DRS, INC.

(Exact name of registrant as specified in its charter)


Delaware001-4156513-2632319 (State of Incorporation)(Commission File Number)(IRS Employer Identification Number)

2345 Crystal Drive Suite 1000 Arlington, Virginia 22202 (Address of principal executive offices) (703) 416-8000 (Registrant's telephone number, including area code)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of class Trading Symbol Name of each exchange on which registered

Common Stock, $0.01 par value DRS Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

Item 2.02. Results of Operation and Financial Condition. On May 1, 2024, Leonardo DRS, Inc. (the “Company”) issued a news release reporting, among other things, its financial results for the first quarter ended March 31, 2024. A copy of the news release is furnished as Exhibit 99.1 to this report. The Company’s management will discuss operations and financial results in an earnings conference call beginning at 10:00 a.m. Eastern Time on May 1, 2024. A live audio broadcast of the conference call along with a supplemental presentation will be available to the public through links on the Investor Relations section of the Company’s web site (https://investors.leonardodrs.com/). The information furnished pursuant to this Form 8-K (including the exhibits hereto) shall not be considered “filed” under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or under the Exchange Act, unless the Company expressly states in such filing that such information is to be considered “filed” or incorporated by reference therein. Item 7.01 Regulation FD Disclosure. The information in Item 2.02 of this report is incorporated by reference into this Item 7.01.

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Exhibit Description 99.1 Leonardo DRS, Inc. News Release dated May 1, 2024 (earnings release reporting Leonardo DRS, Inc.'s financial results for the quarter ended March 31, 2024). 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LEONARDO DRS, INC.

(Registrant)

Date: May 1, 2024 By: /s/ Mark A. Dorfman

Mark A. Dorfman

Executive Vice President, General Counsel and Secretary

2023
Q4

Q4 2023 Earnings

8-K

Mar 14, 2024

0001628280-24-011093

drs-20240314FALSE000183375600018337562024-03-142024-03-14

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 14, 2024


LEONARDO DRS, INC.

(Exact name of registrant as specified in its charter)


Delaware001-4156513-2632319 (State of Incorporation)(Commission File Number)(IRS Employer Identification Number)

2345 Crystal Drive Suite 1000 Arlington, Virginia 22202 (Address of principal executive offices) (703) 416-8000 (Registrant's telephone number, including area code)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of class Trading Symbol Name of each exchange on which registered

Common Stock, $0.01 par value DRS Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

Item 2.02. Results of Operation and Financial Condition. On March 14, 2024, Leonardo DRS, Inc. (the “Company”) issued a news release reporting, among other things, the reaffirmation of its financial guidance previously issued on February 27, 2024, the initiation of a three year framework for revenue, adjusted EBITDA and free cash flow as well as information related to targeted capital deployment. A copy of the news release is furnished as Exhibit 99.1 to this report. The Company previously announced its investor day webcast on March 14, 2024. A replay of the webcast along with a supplemental presentation will be available to the public through links on the Investor Relations section of the Company’s web site (https://investors.leonardodrs.com/). The information furnished pursuant to this Form 8-K (including the exhibits hereto) shall not be considered “filed” under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or under the Exchange Act, unless the Company expressly states in such filing that such information is to be considered “filed” or incorporated by reference therein.

Item 7.01 Regulation FD Disclosure. The information in Item 2.02 of this Form 8-K is incorporated by reference into this Item 7.01.

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Exhibit Description 99.1 Leonardo DRS, Inc. News Release dated March 14, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LEONARDO DRS, INC.

(Registrant)

Date: March 14, 2024 By: /s/ Mark A. Dorfman

Mark A. Dorfman

Executive Vice President, General Counsel and Secretary

2023
Q4

Q4 2023 Earnings

8-K

Feb 27, 2024

0001628280-24-007046

drs-20240227FALSE000183375600018337562024-02-272024-02-27

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2024


LEONARDO DRS, INC.

(Exact name of registrant as specified in its charter)


Delaware001-4156513-2632319 (State of Incorporation)(Commission File Number)(IRS Employer Identification Number)

2345 Crystal Drive Suite 1000 Arlington, Virginia 22202 (Address of principal executive offices) (703) 416-8000 (Registrant's telephone number, including area code)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of class Trading Symbol Name of each exchange on which registered

Common Stock, $0.01 par value DRS Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

Item 2.02. Results of Operation and Financial Condition. On February 27, 2024, Leonardo DRS, Inc. (the “Company”) issued a news release reporting, among other things, its financial results for the fourth quarter and full year ended December 31, 2023 and providing its financial outlook for full year 2024. A copy of the news release is furnished as Exhibit 99.1 to this report. The Company’s management will discuss operations and financial results in a previously announced earnings conference call beginning at 10:00 a.m. Eastern Time on February 27, 2024. A live audio broadcast of the conference call along with a supplemental presentation will be available to the public through links on the Investor Relations section of the Company’s web site (https://investors.leonardodrs.com/). The information furnished pursuant to this Form 8-K (including the exhibits hereto) shall not be considered “filed” under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or under the Exchange Act, unless the Company expressly states in such filing that such information is to be considered “filed” or incorporated by reference therein.

Item 7.01 Regulation FD Disclosure. The information in Item 2.02 of this Form 8-K is incorporated by reference into this Item 7.01.

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Exhibit Description 99.1 Leonardo DRS, Inc. News Release dated February 27, 2024 (earnings release reporting Leonardo DRS, Inc.'s financial results for the quarter and full year ended December 31, 2023). 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LEONARDO DRS, INC.

(Registrant)

Date: February 27, 2024 By: /s/ Mark A. Dorfman

Mark A. Dorfman

Executive Vice President, General Counsel and Secretary

2023
Q3

Q3 2023 Earnings

8-K

Nov 2, 2023

0001628280-23-036227

drs-20231102FALSE000183375600018337562023-11-022023-11-02

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2023


LEONARDO DRS, INC.

(Exact name of registrant as specified in its charter)


Delaware001-4156513-2632319 (State of Incorporation)(Commission File Number)(IRS Employer Identification Number)

2345 Crystal Drive Suite 1000 Arlington, Virginia 22202 (Address of principal executive offices) (703) 416-8000 (Registrant's telephone number, including area code)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of class Trading Symbol Name of each exchange on which registered

Common Stock, $0.01 par value DRS Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

Item 2.02. Results of Operation and Financial Condition. On November 2, 2023, Leonardo DRS, Inc. (the “Company”) issued a news release reporting, among other things, its financial results for the third quarter ended September 30, 2023. A copy of the news release is furnished as Exhibit 99.1 to this report. The Company’s management will discuss operations and financial results in an earnings conference call beginning at 10:00 a.m. Eastern Time on November 2, 2023. A live audio broadcast of the conference call along with a supplemental presentation will be available to the public through links on the Investor Relations section of the Company’s web site (https://investors.leonardodrs.com/). The information furnished pursuant to this Form 8-K (including the exhibits hereto) shall not be considered “filed” under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or under the Exchange Act, unless the Company expressly states in such filing that such information is to be considered “filed” or incorporated by reference therein.

Item 7.01 Regulation FD Disclosure. The information in Item 2.02 of this Form 8-K is incorporated by reference into this Item 7.01.

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Exhibit Description 99.1 Leonardo DRS, Inc. News Release dated November 2, 2023 (earnings release reporting Leonardo DRS, Inc.'s financial results for the quarter ended September 30, 2023). 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LEONARDO DRS, INC.

(Registrant)

Date: November 2, 2023 By: /s/ Mark A. Dorfman

Mark A. Dorfman

Executive Vice President, General Counsel and Secretary

2023
Q2

Q2 2023 Earnings

8-K

Aug 2, 2023

0001628280-23-026590

drs-20230802FALSE000183375600018337562023-08-022023-08-02

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2023


LEONARDO DRS, INC.

(Exact name of registrant as specified in its charter)


Delaware001-4156513-2632319 (State of Incorporation)(Commission File Number)(IRS Employer Identification Number)

2345 Crystal Drive Suite 1000 Arlington, Virginia 22202 (Address of principal executive offices) (703) 416-8000 (Registrant's telephone number, including area code)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of class Trading Symbol Name of each exchange on which registered

Common Stock, $0.01 par value DRS Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

Item 2.02. Results of Operation and Financial Condition. On August 2, 2023, Leonardo DRS, Inc. (the “Company”) issued a news release reporting, among other things, its financial results for the second quarter ended June 30, 2023. A copy of the news release is furnished as Exhibit 99.1 to this report. The Company’s management will discuss operations and financial results in an earnings conference call beginning at 10:30 a.m. Eastern Time on August 2, 2023. A live audio broadcast of the conference call along with a supplemental presentation will be available to the public through links on the Investor Relations section of the Company’s web site (https://investors.leonardodrs.com/). The information furnished pursuant to this Form 8-K (including the exhibits hereto) shall not be considered “filed” under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or under the Exchange Act, unless the Company expressly states in such filing that such information is to be considered “filed” or incorporated by reference therein.

Item 7.01 Regulation FD Disclosure. The information in Item 2.02 of this Form 8-K is incorporated by reference into this Item 7.01.

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Exhibit Description 99.1 Leonardo DRS, Inc. News Release dated August 2, 2023 (earnings release reporting Leonardo DRS, Inc.'s financial results for the quarter ended June 30, 2023). 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LEONARDO DRS, INC.

(Registrant)

Date: August 2, 2023 By: /s/ Mark A. Dorfman

Mark A. Dorfman

Executive Vice President, General Counsel and Secretary

2023
Q2

Q2 2023 Earnings

8-K

Jul 28, 2023

0001628280-23-026102

drs-20230728FALSE000183375600018337562023-07-282023-07-28

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 28, 2023


LEONARDO DRS, INC.

(Exact name of registrant as specified in its charter)


Delaware001-4156513-2632319 (State of Incorporation)(Commission File Number)(IRS Employer Identification Number)

2345 Crystal Drive Suite 1000 Arlington, Virginia 22202 (Address of principal executive offices) (703) 416-8000 (Registrant's telephone number, including area code)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of class Trading Symbol Name of each exchange on which registered

Common Stock, $0.01 par value DRS The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

Item 2.02. Results of Operation and Financial Condition. On July 28, 2023, Leonardo DRS, Inc.’s (the “Company”) majority stockholder, Leonardo S.p.A., an Italian società per azioni, listed on the Milan Stock Exchange (“Leonardo S.p.A”), of which the Company is a consolidated subsidiary, issued a press release announcing its consolidated financial results for the half year ended June 30, 2023 (the “Press Release”) as well as a presentation related to the release of its consolidated financial results for the half year ended June 30, 2023 (the “Presentation”), which are attached hereto as Exhibit 99.1 and 99.2 respectively. The Presentation was followed by a live question and answer webcast (the “Q&A”). A transcript of the Presentation and Q&A is attached hereto as Exhibit 99.3. The financial information contained in these materials includes, on a consolidated basis, information regarding the Company’s results of operations and financial condition in accordance with International Financial Reporting Standards (“IFRS”), including but not limited to the financial information regarding the Company’s performance in the first half of 2023 in the table on page 10 of the Press Release, which differs in some respects from the accounting principles generally accepted in the United States of America (“U.S. GAAP”). As previously announced, the Company plans to issue its quarterly earnings press release on August 2, 2023, which will contain financial information of the Company for the second quarter 2023 in accordance with U.S. GAAP. The Press Release, Presentation, and transcript of the Presentation prepared remarks and Q&A are attached hereto as Exhibit 99.1, Exhibit 99.2, and Exhibit 99.3, respectively, and are being furnished to the Securities and Exchange Commission under both Item 2.02 “Results of Operations and Financial Condition” and Item 7.01 “Regulation FD Disclosure” of Form 8-K. The information furnished pursuant to this Form 8-K (including the exhibits hereto) shall not be considered “filed” under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or under the Exchange Act, unless the Company expressly states in such filing that such information is to be considered “filed” or incorporated by reference therein.

Item 7.01 Regulation FD Disclosure. To the extent applicable, the information in Item 2.02 of this Form 8-K is incorporated by reference into this Item 7.01.

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Exhibit Description 99.1 Leonardo S.p.A.’s HY 2023 Press Release 99.2 Leonardo S.p.A.’s HY 2023 Presentation 99.3 Leonardo S.p.A.’s HY 2023 Presentation and Q&A Transcript 104 Cover Page Interac

2023
Q1

Q1 2023 Earnings

8-K

May 3, 2023

0001628280-23-015213

drs-20230503FALSE000183375600018337562023-05-032023-05-03

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2023


LEONARDO DRS, INC.

(Exact name of registrant as specified in its charter)


Delaware001-4156513-2632319 (State of Incorporation)(Commission File Number)(IRS Employer Identification Number)

2345 Crystal Drive Suite 1000 Arlington, Virginia 22202 (Address of principal executive offices) (703) 416-8000 (Registrant's telephone number, including area code)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of class Trading Symbol Name of each exchange on which registered

Common Stock, $0.01 par value DRS Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

Item 2.02. Results of Operations and Financial Condition. On May 3, 2023, Leonardo DRS, Inc. (the “Company”) issued a news release reporting, among other things, its financial results for the first quarter ended March 31, 2023. A copy of the news release is furnished as Exhibit 99.1 to this report. The Company’s management will discuss operations and financial results in an earnings conference call beginning at 5:00 p.m. Eastern Time on May 3, 2023. A live audio broadcast of the conference call along with a supplemental presentation will be available to the public through links on the Investor Relations section of the Company’s web site (https://investors.leonardodrs.com/). The information furnished pursuant to this Form 8-K (including the exhibits hereto) shall not be considered “filed” under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or under the Exchange Act, unless the Company expressly states in such filing that such information is to be considered “filed” or incorporated by reference therein.

Item 7.01 Regulation FD Disclosure. The information in Item 2.02 of this Form 8-K is incorporated by reference into this Item 7.01.

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Exhibit Description 99.1 Leonardo DRS, Inc. News Release dated May 3, 2023 (earnings release reporting Leonardo DRS, Inc.'s financial results for the quarter ended March 31, 2023). 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LEONARDO DRS, INC.

(Registrant)

Date: May 3, 2023 By: /s/ Mark A. Dorfman

Mark A. Dorfman

Executive Vice President, General Counsel and Secretary

2022
Q4

Q4 2022 Earnings

8-K

Mar 28, 2023

0001628280-23-009346

drs-20230328FALSE000183375600018337562023-03-282023-03-28

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 28, 2023


LEONARDO DRS, INC.

(Exact name of registrant as specified in its charter)


Delaware001-4156513-2632319 (State of Incorporation)(Commission File Number)(IRS Employer Identification Number)

2345 Crystal Drive Suite 1000 Arlington, Virginia 22202 (Address of principal executive offices) (703) 416-8000 (Registrant's telephone number, including area code)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of class Trading Symbol Name of each exchange on which registered

Common Stock, $0.01 par value DRS Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

Item 2.02. Results of Operation and Financial Condition. On March 28, 2023, Leonardo DRS, Inc. (the “Company”) issued a news release reporting, among other things, its financial results for the fourth quarter and fiscal year ended December 31, 2022. A copy of the news release is furnished as Exhibit 99.1 to this report. The Company’s management will discuss operations and financial results in an earnings conference call beginning at 10:30 a.m. Eastern Time on March 28, 2023. A live audio broadcast of the conference call along with a supplemental presentation will be available to the public through links on the Investor Relations section of the Company’s web site (https://investors.leonardodrs.com/). The information furnished pursuant to this Form 8-K (including the exhibits hereto) shall not be considered “filed” under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or under the Exchange Act, unless the Company expressly states in such filing that such information is to be considered “filed” or incorporated by reference therein.

Item 7.01 Regulation FD Disclosure. The information in Item 2.02 of this Form 8-K is incorporated by reference into this Item 7.01.

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Exhibit Description 99.1 Leonardo DRS, Inc. News Release dated March 28, 2023 (earnings release reporting Leonardo DRS, Inc.'s financial results for the quarter and year ended December 31, 2022). 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LEONARDO DRS, INC.

(Registrant)

Date: March 28, 2023 By: /s/ Mark A. Dorfman

Mark A. Dorfman

Executive Vice President, General Counsel and Secretary

2022
Q4

Q4 2022 Earnings

8-K

Mar 10, 2023

0001628280-23-007455

drs-20230310FALSE000183375600018337562023-03-102023-03-10

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 10, 2023


LEONARDO DRS, INC.

(Exact name of registrant as specified in its charter)


Delaware001-4156513-2632319 (State of Incorporation)(Commission File Number)(IRS Employer Identification Number)

2345 Crystal Drive Suite 1000 Arlington, Virginia 22202 (Address of principal executive offices) (703) 416-8000 (Registrant's telephone number, including area code)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of class Trading Symbol Name of each exchange on which registered

Common Stock, $0.01 par value DRS The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

Item 2.02. Results of Operation and Financial Condition. On March 10, 2023, Leonardo DRS, Inc.’s (the “Company”) majority stockholder, Leonardo S.p.A., an Italian società per azioni, listed on the Milan Stock Exchange, (“Leonardo S.p.A”), of which the Company is a consolidated subsidiary, issued a presentation related to the release of its consolidated financial results for the year ended December 31, 2022 (the “Presentation”), which is attached hereto as Exhibit 99.1, and includes but is not limited to Company backlog on slide 7 and Company fourth quarter trends on slide 37. A transcript of the Presentation prepared remarks is attached hereto as Exhibit 99.2. The Presentation was followed by a live question and answer webcast (the “Q&A”), a transcript of which is attached hereto as Exhibit 99.3. The financial information contained in these materials includes, on a consolidated basis, information regarding the Company’s results of operations and financial condition in accordance with International Financial Reporting Standards (“IFRS”), which differs in some respects from the accounting principles generally accepted in the United States of America (“U.S. GAAP”). As previously announced, the Company plans to issue its quarterly earnings press release on March 28, 2023, which will contain financial information of the Company for the fourth quarter and the full year 2022 in accordance with U.S. GAAP. The Presentation, the transcript of the Presentation prepared remarks and transcript of the Q&A are attached hereto as Exhibit 99.1, Exhibit 99.2 and Exhibit 99.3, respectively, are being furnished to the SEC under both Item 2.02 “Results of Operations and Financial Condition” and Item 7.01 “Regulation FD Disclosure” of Form 8-K. The information furnished pursuant to this Form 8-K (including the exhibits hereto) shall not be considered “filed” under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or under the Exchange Act, unless the Company expressly states in such filing that such information is to be considered “filed” or incorporated by reference therein.

Item 7.01 Regulation FD Disclosure. To the extent applicable, the information in Item 2.02 of this Form 8-K is incorporated by reference into this Item 7.01.

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Exhibit Description 99.1 Leonardo S.p.A.’s Presentation regarding the 2022 Integrated Annual Report 99.2 A Transcript of Leonardo S.p.A.’s Presentation regarding the FY 2022 Integrated Annual Report 99.3 A Transcript of the March 10, 2023 Leonardo S.p.A. Live Questions and Answers Webcast following the Presentation regarding the 2022 Integrated Annual Repo

2022
Q4

Q4 2022 Earnings

8-K

Mar 10, 2023

0001628280-23-007451

drs-20230309FALSE000183375600018337562023-03-092023-03-09

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 9, 2023


LEONARDO DRS, INC.

(Exact name of registrant as specified in its charter)


Delaware001-4156513-2632319 (State of Incorporation)(Commission File Number)(IRS Employer Identification Number)

2345 Crystal Drive Suite 1000 Arlington, Virginia 22202 (Address of principal executive offices) (703) 416-8000 (Registrant's telephone number, including area code)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of class Trading Symbol Name of each exchange on which registered

Common Stock, $0.01 par value DRS The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

Item 2.02. Results of Operation and Financial Condition. On March 9, 2023, Leonardo DRS, Inc.’s (the “Company”) majority stockholder, Leonardo S.p.A., an Italian società per azioni, listed on the Milan Stock Exchange, (“Leonardo S.p.A”), of which the Company is a consolidated subsidiary, issued a press release announcing consolidated financial results for the year ended December 31, 2022 (the "Press Release”), which is attached hereto as Exhibit 99.1, as well as its Integrated Annual Report for the year ended December 31, 2023 (the “Annual Report”) which is attached hereto as Exhibit 99.2. The financial information contained in these materials includes, on a consolidated basis, information regarding the Company’s results of operations and financial condition in accordance with International Financial Reporting Standards (“IFRS”), including but not limited to the financial information regarding the Company’s performance in 2022 in the table on page 17 of the Press Release, which differs in some respects from the accounting principles generally accepted in the United States of America (“U.S. GAAP”). As previously announced, the Company plans to issue its quarterly earnings press release on March 28, 2023, which will contain financial information of the Company for the fourth quarter and the full year 2022 in accordance with U.S. GAAP. The Press Release and the Annual Report are attached hereto as Exhibit 99.1 and Exhibit 99.2, respectively, are being furnished to the SEC under both Item 2.02 “Results of Operations and Financial Condition” and Item 7.01 “Regulation FD Disclosure” of Form 8-K. The information furnished pursuant to this Form 8-K (including the exhibits hereto) shall not be considered “filed” under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or under the Exchange Act, unless the Company expressly states in such filing that such information is to be considered “filed” or incorporated by reference therein.

Item 7.01 Regulation FD Disclosure. To the extent applicable, the information in Item 2.02 of this Form 8-K is incorporated by reference into this Item 7.01.

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Exhibit Description 99.1 Leonardo S.p.A.’s FY 2022 Press Release 99.2 Leonardo S.p.A.’s FY 2022 Integrated Annual Report 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LEONARDO DRS, INC.

(Registrant)

Date: March 10, 2023 By: /s/ Mark A. Dorfman

Mark

About Leonardo DRS Inc. (DRS) Earnings

This page provides Leonardo DRS Inc. (DRS) earnings call transcripts from SEC 8-K filings along with AI-powered predictions for post-earnings price movements. Our machine learning models analyze historical earnings data, pre-earnings price patterns, volume changes, and volatility to predict 1-day, 5-day, and 20-day returns after each earnings release.

Earnings transcripts are sourced directly from SEC EDGAR filings. Predictions are generated using gradient boosting models trained on DRS's historical earnings reactions. All predicted returns are shown as percentages, and predicted prices are calculated from the closing price at the time of prediction. Past performance does not guarantee future results.

Share on Social Networks: